[Effect of carbimazole and dexamethasone on the TSH bond (TBII) inhibiting immunoglobulins in Graves-Basedow disease].
Obiols Alfonso
G
G
Mesa Manteca
J
J
Simó Canonge
R
R
García Pascual
L
L
García Alonso
C
C
Tresánchez Trías
J M
JM
D002231:Carbimazole / Q000008:administration & dosage / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003907:Dexamethasone / Q000008:administration & dosage / Q000494:pharmacology*; D004341:Drug Evaluation; D006111:Graves Disease / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis / Q000276:immunology*; D018828:Immunoglobulins, Thyroid-Stimulating
D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D003907:Dexamethasone; D002231:Carbimazole
Efecto del carbimazol y la dexametasona sobre las inmunoglobulinas inhibidoras de la unión de la TSH (TBII) en la enfermedad de Graves-Basedow.